Advertisement

Topics

ImmunoRestoration Announces Exclusive License to Immunotherapeutic Cancer Vaccine Platform from the University of Pennsylvania

12:40 EDT 14 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company to Accelerate Research on Groundbreaking Platform ImmunoRestoration, Inc., a company recently formed to lead the development and commercialization of a novel immunotherapeutic cancer vaccine platform, today announced...

Other Sources for this Article

ImmunoRestoration, Inc.
Peter Malamis
p.malamis@immunorestoration.com

NEXT ARTICLE

More From BioPortfolio on "ImmunoRestoration Announces Exclusive License to Immunotherapeutic Cancer Vaccine Platform from the University of Pennsylvania"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...